Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 30, 2015 12:35 AM ET

Healthcare Equipment and Supplies

Company Overview of Teikoku Seiyaku Co., Ltd.

Company Overview

Teikoku Seiyaku Co., Ltd. engages in the development, manufacture, and sale of medicated and medically related supplies. It offers a range of hot sensation, and analgesic and anti-inflammatory plasters. The company, through its subsidiaries, also engages in the research, development, and manufacture of pharmaceutical transdermal products; and production and sale of medical adhesive products and external aqueous gel preparations. Its transdermal products include Lidoderm, a prescription hydrogel patch for the treatment of post-herpetic neuralgia; IontoPatch, an extended time-released electronic transdermal drug delivery system; Envela, a dressing for use in the management of psoriasis and the...

567 Sanbonmatsu

Higashikagawa,  769-2695


Founded in 1848


81 879 25 2221


81 879 24 1555

Key Executives for Teikoku Seiyaku Co., Ltd.

Chief Executive Officer, President and Director
Age: 60
Chief Operating Officer, Executive Vice President and Director
Managing Director and Director
Age: 58
Senior Managing Director and Director
Senior Managing Director and Director
Compensation as of Fiscal Year 2015.

Teikoku Seiyaku Co., Ltd. Key Developments

Teikoku Seiyaku Co., Ltd. Presents at BIO-Europe 2015, Nov-02-2015

Teikoku Seiyaku Co., Ltd. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.

Noven Pharmaceuticals, Inc. Announces Settlement of Lidoderm(R) Patent Litigation with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc

Noven Pharmaceuticals, Inc. announced that it has entered into an agreement with Endo Pharmaceuticals Inc., Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc. to settle all outstanding patent litigation related to Noven's lidocaine topical patch 5% product. An Abbreviated New Drug Application for Noven's product is currently pending at the U.S. Food and Drug Administration (FDA). If approved, Noven's product would be a generic version of Endo's Lidoderm(R). The agreement allows Noven to launch its generic Lidoderm(R) product on or after March 1, 2015, if the product is approved by the FDA. The agreement provides for an earlier launch under certain circumstances. Pursuant to the agreement, the litigation on this matter, currently pending in U.S. District Court for the District of Delaware, will be dismissed. Other terms of the settlement were not disclosed. The settlement agreement is subject to review by the U.S. Federal Trade Commission and the U.S. Department of Justice.

Similar Private Companies By Industry

Company Name Region
SofticJapan Co., Ltd. Asia
Asahi Co.,Ltd. Asia
CREWT Medical Systems, Inc. Asia
Siemens Hearing Instruments K.K. Asia

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Teikoku Seiyaku Co., Ltd., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at